-
Real‐world effectiveness of cenobamate in drug‐resistant and ultra‐refractory epilepsy: A multicenter study
-
Effectiveness of adjunctive low‐dose clobazam in adults with focal drug‐resistant epilepsy and incomplete response to cenobamate: A real‐world study
-
Eculizumab in Myasthenia Gravis: A Multicenter Retrospective Real-World Study in China
-
Cenobamate: An Appraisal Five Years On
-
Clinical Characteristics, Treatment Patterns, and Drug-Resistant Epilepsy Among Emirati Adults with Epilepsy
-
Perampanel as add‐on in high‐grade glioma–related epilepsy: Seizure control and QoL in a prospective, multicenter, real‐world 6‐month follow‐up study
-
Real‐world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2‐q13.1 duplication and deletion syndromes: A multicenter study
-
Epilepsy‐Related Psychosis in Drug‐Resistant Epilepsy With Nonconvulsive Status Epilepticus and Difficult Antipsychotic Titration: A Case Report
-
Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis
-
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
-
A first in disease trial of the safety, tolerability, and anti‐seizure effects of ES‐481 in drug‐resistant epilepsy
-
Expanding the scope of pediatric epilepsy surgery: Access, indications, and outcomes in a modern cohort
-
Hypersensitivity reaction risk when restarting cenobamate after discontinuation: Insights from a prolonged hospitalized cohort
-
A Real-Time Epilepsy Detection Method Using Embedded Zero Tree Wavelet Approach and Support Vector Machine
-
Predictors of treatment efficacy in mesial temporal lobe epilepsy and focal epilepsies of other localisations
-
Real‐World Vortioxetine Prescription for Patients With Major Depressive Disorder in Japan: A Retrospective Cohort Study Using a Japanese Health Insurance Claims Database
-
The Global Epilepsy Needs Study (GENS): A mixed‐methods, multi‐country exploration of the unmet psychosocial and everyday needs of people with epilepsy
-
Incorporation bias in clinical prediction models for epilepsy
-
Descriptive Analysis of Retrospective Observational Real-World Evidence of a Monoclonal Anti-Amyloid Therapy Program in a Wide Catchment Specialty Memory Clinic
-
Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
-
What does it take to make real‐world changes in schizophrenia care?
-
Widening participation in the International League Against Epilepsy: Looking to the future
-
The Burden of Epilepsy in Thailand: Estimating Societal Costs and Quality of Life
-
Occurrence and clinical correlates of depressive symptoms in adults with epilepsy: A study in Georgia
